Cargando…
Anthracycline-induced cardiotoxicity in the chemotherapy treatment of breast cancer: Preventive strategies and treatment
Anthracyclines are highly effective chemotherapeutic agents, used for a wide variety of malignancies. Cardiotoxicity is a well-recognized side effect of anthracycline therapy that limits the total amount of drug administered and can cause heart failure in some patients. Most experimental data suppor...
Autores principales: | Cai, Fengfeng, Luis, Manuel Antonio Falar, Lin, Xiaoyan, Wang, Minghong, Cai, Lu, Cen, Chunmei, Biskup, Ewelina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535635/ https://www.ncbi.nlm.nih.gov/pubmed/31289672 http://dx.doi.org/10.3892/mco.2019.1854 |
Ejemplares similares
-
Prognostic role of Tif1γ expression and circulating tumor cells in patients with breast cancer
por: Cai, Fengfeng, et al.
Publicado: (2019) -
Anthracycline Chemotherapy and Cardiotoxicity
por: McGowan, John V, et al.
Publicado: (2017) -
Pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity
por: Chung, Woo-Baek, et al.
Publicado: (2016) -
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
por: Bansal, Neha, et al.
Publicado: (2019) -
Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer
por: Macedo, Ariane V.S., et al.
Publicado: (2019)